NDC 55150-230 – Fondaparinux Sodium
Fondaparinux Sodium 2.5 mg/.5mL · Injection, Solution · Subcutaneous
Product NDC55150-230
Product details
- Brand name
- Fondaparinux Sodium
- Generic name
- Fondaparinux Sodium
- Labeler
- Eugia US LLC
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- ANDA · ANDA206918
- Marketed since
- December 26, 2017
- Listing expires
- December 31, 2026
- Pharmacologic class
- Factor Xa Inhibitor
Active ingredients
- Fondaparinux Sodium 2.5 mg/.5mL
Uses, dosage, side effects and warnings for Fondaparinux Sodium →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 55150-230-02 | 2 SYRINGE, GLASS in 1 CARTON (55150-230-02) / .5 mL in 1 SYRINGE, GLASS (55150-230-00) | Dec 26, 2017 |
| 55150-230-10 | 10 SYRINGE, GLASS in 1 CARTON (55150-230-10) / .5 mL in 1 SYRINGE, GLASS (55150-230-00) | Dec 26, 2017 |
Recalls mentioning this NDC
- D-0020-2023 Nov 2, 2022 · Class II
Subpotent Drug: Out of specification for assay
Other Fondaparinux Sodium products
- 55150-231 Fondaparinux Sodium 5 mg/.4mL · Injection, Solution · Eugia US LLC
- 55150-232 Fondaparinux Sodium 7.5 mg/.6mL · Injection, Solution · Eugia US LLC
- 55150-233 Fondaparinux Sodium 10 mg/.8mL · Injection, Solution · Eugia US LLC
- 11797-154 Fondaparinux Sodium 2.5 mg/.5mL · Injection, Solution · Italfarmaco S.p.A
- 11797-155 Fondaparinux Sodium 5 mg/.4mL · Injection, Solution · Italfarmaco S.p.A
- 11797-156 Fondaparinux Sodium 7.5 mg/.6mL · Injection, Solution · Italfarmaco S.p.A
- 11797-157 Fondaparinux Sodium 10 mg/.8mL · Injection, Solution · Italfarmaco S.p.A
- 67457-585 Fondaparinux Sodium 10 mg/.8mL · Injection, Solution · Mylan Institutional LLC
- 67457-584 Fondaparinux Sodium 7.5 mg/.6mL · Injection, Solution · Mylan Institutional LLC
- 67457-583 Fondaparinux Sodium 5 mg/.4mL · Injection, Solution · Mylan Institutional LLC
- 67457-582 Fondaparinux Sodium 2.5 mg/.5mL · Injection, Solution · Mylan Institutional LLC
- 70710-1517 Fondaparinux Sodium 10 mg/.8mL · Injection, Solution · Zydus Pharmaceuticals (USA) Inc.